Skip navigation
Browsing by Author Burge, M.
Showing results 1 to 2 of 2
| Preview | Issue Date | Title / Name | Author(s) |
| Aug-2021 | MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG) | Siu, H. W. D.; Tebbutt, N.; Chantrill, L.; Karapetis, C.; Steer, C.; Wilson, K.; Espinoza, D.; Bailey, L.; Yip, S.; Cuff, J.; Pavlakis, N.; Thavaneswaran, S.; Briscoe, K.; Srivastav, R.; Shannon, J.; Segelov, E.; Tie, J.; Caird, S.; Francesconi, A.; Price, T.; Wuttke, M.; Ladwa, R.; Sjoquist, K.; Burge, M.; Briscoe, Karen | |
| Mar-2021 | Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status | Travers, A.; Jalali, A.; Begbie, S.; Semira, C.; Kosmider, S.; Ananda, S.; Wong, R.; Lee, M.; Shapiro, J.; Burge, M.; Yip, D.; Torres, J.; Ma, B.; Nott, L.; Dean, A.; Tie, J.; Khattak, A.; Lim, S.; Wong, H. L.; Gibbs, P.; Begbie, Stephen | |
